Cytoprotective benzofuran derivatives
CA 2474974 A1 · Owner: Galileo Pharmaceuticals, Inc. · Inventors: Chen, Jian; Wang, Bing
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Cytoprotective compounds, many of which are benzofuran derivatives are useful in the treatment of certain ischemic or inflammatory conditions including but , not limited to stroke, myocardial infarction congestive heart failure, and , skin disorders characterized by inflammation or oxidative damage. They are also useful in the manufacture of pharmaceutical and cosmetic formulations for the treatment of such conditions.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 6, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 6, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 6, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.